Suffolk Reporter

The Department of Microbiology and Immunology at Stony Brook University's Renaissance School of Medicine has been recognized as a "Milestones in Microbiology" site by the American Society for Microbiology (ASM). This honor highlights the department's contributions to diagnosing and treating infectious diseases worldwide. The ASM designation acknowledges programs where "major developments and pivotal discoveries occurred."

Stony Brook's department is the 20th program nationwide, third in New York State, and second on Long Island to receive this distinction. Faculty members gathered on October 17 at a ceremony at Stony Brook University to celebrate the recognition. They were presented with a plaque from ASM that honors their significant research since the department's founding in 1972.

David Thanassi, PhD, chair of the Department of Microbiology and Immunology, expressed pride in receiving this recognition: “The designation of the Department of Microbiology and Immunology as a Milestones in Microbiology Site is an honor and recognizes the impact the Department has made through its groundbreaking discoveries.”

Theresa Koehler, PhD, President of ASM, praised Stony Brook University’s work: “ASM is delighted to recognize Stony Brook University’s Department of Microbiology and Immunology as a ‘Milestones in Microbiology’ site for its significant contributions to the microbial sciences.”

The department has been acknowledged for its extensive research over five decades. Its achievements include pioneering studies in molecular biology related to DNA structure and RNA regulatory mechanisms. These efforts have influenced Nobel prize-winning research on regulatory RNAs.

Significant contributions also include findings related to tumor formation and cancer research. The department has been at the forefront of studying pathogenic viruses, bacteria, and fungi, providing insights into infection mechanisms that have informed therapeutic development.

Carol Carter, PhD, Distinguished Professor within the department stated: “As a member of the faculty for several decades, it has been inspiring to witness the emergence of ideas and findings in which outcomes have had such tremendous impact.”

Recent departmental work includes advancing knowledge about herpesviruses' role in establishing infections, understanding Adenovirus replication better, and examining bacterial appendages involved in kidney infections.

Peter Igarashi, MD, Dean of RSOM highlighted future aspirations: “Although the Milestones in Microbiology designation commemorates past accomplishments, it also sets the stage for future innovations.” He noted strong funding success with 17 grants totaling over $8 million from NIH this fiscal year.

At the ceremony, they received additional honors including a Certificate of Recognition and a Proclamation by New York State Assemblyman Hon. Ed Flood.